The effects of metformin on metabolic and cardiovascular risk factors in nonobese women with polycystic ovary syndrome

Sahin Y., Unluhizarci K., Yılmazsoy A., Yıkılmaz A., Aygen E., Kelestimur F.

CLINICAL ENDOCRINOLOGY, vol.67, no.6, pp.904-908, 2007 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 67 Issue: 6
  • Publication Date: 2007
  • Doi Number: 10.1111/j.1365-2265.2007.02985.x
  • Journal Name: CLINICAL ENDOCRINOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.904-908
  • Erciyes University Affiliated: Yes

Abstract

Objective There are conflicting data regarding the effects of metformin in lean women with polycystic ovary syndrome (PCOS). Thus, our aim was to evaluate the effects of 6 months of metformin therapy on various metabolic and cardiovascular risk factors in lean women with PCOS.